Caris Life Sciences Launches Campaign Highlighting AI-Driven Diagnostic Successes in Cancer Treatment
Caris Life Sciences has initiated a new campaign titled 'Behind the Diagnosis' to showcase the transformative impact of its AI-powered genomic testing on patient care. The campaign's inaugural story features Erika Rios, whose initial diagnosis of stage 4 metastatic triple-negative breast cancer was corrected to Hodgkin lymphoma through Caris' GPSai model. This AI-driven model, integrated into Caris' molecular profiling, identified the true source of her disease, allowing for a more effective treatment plan. The campaign aims to highlight real-world clinical outcomes made possible by Caris' comprehensive genomic profiling and AI technology, which provides a second look at diagnoses without additional specimen requirements. 
